Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
68.51
+0.81 (1.20%)
At close: Jun 27, 2025, 4:00 PM
68.45
-0.06 (-0.09%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Novo Nordisk stock ranges from a low of $64 to a high of $160. The average analyst price target of $112 forecasts a 63.48% increase in the stock price over the next year.
Price Target: $112.00 (+63.48%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 17, 2025.
Analyst Ratings
The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 | 1 |
Buy | 3 | 3 | 3 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BMO Capital | BMO Capital | Buy → Hold Downgrades $105 → $64 | Buy → Hold | Downgrades | $105 → $64 | -6.58% | Apr 17, 2025 |
UBS | UBS | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
BMO Capital | BMO Capital | Buy Maintains $156 → $105 | Buy | Maintains | $156 → $105 | +53.26% | Dec 23, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +133.54% | Nov 6, 2024 |
BMO Capital | BMO Capital | Buy Maintains $160 → $156 | Buy | Maintains | $160 → $156 | +127.70% | Oct 17, 2024 |
Financial Forecast
Revenue This Year
344.40B
from 290.40B
Increased by 18.59%
Revenue Next Year
398.17B
from 344.40B
Increased by 15.61%
EPS This Year
27.09
from 22.63
Increased by 19.72%
EPS Next Year
33.20
from 27.09
Increased by 22.55%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 379.1B | 444.6B | 513.9B | ||
Avg | 344.4B | 398.2B | 442.4B | ||
Low | 312.0B | 346.6B | 375.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 30.5% | 29.1% | 29.1% | ||
Avg | 18.6% | 15.6% | 11.1% | ||
Low | 7.4% | 0.6% | -5.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 32.01 | 40.78 | 46.86 | ||
Avg | 27.09 | 33.20 | 37.37 | ||
Low | 24.55 | 28.09 | 30.69 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 41.5% | 50.5% | 41.1% | ||
Avg | 19.7% | 22.6% | 12.5% | ||
Low | 8.5% | 3.7% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.